Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Pyroxamide in Treating Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation
- Status
- UNKNOWN
- Phase
- PHASE2
Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1
Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Blood and Marrow Transplant Clinical Research Network
- Status
- COMPLETED
- Phase
- NA
Gemtuzumab in Treating Patients With Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE2
Bevacizumab in Treating Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE2
Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2